As debates continue over just how well Obamacare can work (or even if it can), we might be better off investing our energies and hopes in the private sector.
Craig Venter’s latest gene-sequencing venture is a case in point. The scientist and entrepreneur, well known for his privately funded efforts to sequence the first human genome, has launched Human Longevity, a new company that will help people live longer and healthier lives. The company has already raised $70 million from donors.
Read Full Article »